Speciality Medi.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
126.75
0.75 (0.6%)
BSENSE

Apr 02

BSE+NSE Vol: 121000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 111.71% vs 18.43% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 73.16% vs 47.37% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -17.20% vs 73.95% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 193.43% vs 73.70% in Mar 2024

Compare Profit and Loss Results of Speciality Medi.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
58.00
118.00
-60.00
-50.85%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
58.00
118.00
-60.00
-50.85%
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
-3.00
-6.00
-200.00%
Raw Materials Consumed
51.00
74.00
-23.00
-31.08%
Power & Fuel Cost
0.00
5.00
-5.00
-100.00%
Employee Cost
2.00
13.00
-11.00
-84.62%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
2.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
49.00
98.00
-49.00
-50.00%
Operating Profit (PBDIT) excl Other Income
9.00
20.00
-11.00
-55.00%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
9.00
21.00
-12.00
-57.14%
Interest
0.00
4.00
-4.00
-100.00%
Profit before Depriciation and Tax
8.00
17.00
-9.00
-52.94%
Depreciation
0.00
3.00
-3.00
-100.00%
Profit Before Taxation & Exceptional Items
8.00
13.00
-5.00
-38.46%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8.00
13.00
-5.00
-38.46%
Provision for Tax
0.00
4.00
-4.00
-100.00%
Profit After Tax
8.00
9.00
-1.00
-11.11%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
5.00
-10.00
15.00
150.00%
Profit Available for appropriations
13.00
0.00
13.00
0%
Appropriations
13.00
0.00
13.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
14.1
2.03
12.07
594.58%
Profit And Loss - Net Sales
Net Sales 58.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 111.71% vs 18.43% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.13 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 73.16% vs 47.37% in Mar 2024

Profit And Loss - Interest
Interest 0.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.20% vs 73.95% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 8.61 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 193.43% vs 73.70% in Mar 2024